These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35891212)

  • 21. To Boost or Not to Boost: Acceptability of a COVID-19 Booster Dose among Osteopathic Medical Students: A Cross-Sectional Study from a Medical School in New York.
    Al Janabi T; Pino M
    Epidemiologia (Basel); 2022 Apr; 3(2):218-228. PubMed ID: 36417253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience.
    Alobaidi S; Alsolami E; Sherif A; Almahdy M; Elmonier R; Alobaidi WY; Akl A
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
    Ghazy RM; Abdou MS; Awaidy S; Sallam M; Elbarazi I; Youssef N; Fiidow OA; Mehdad S; Hussein MF; Adam MF; Abdullah FSA; Rebai WK; Raad EB; Hussein M; Shehata SF; Ismail II; Salam AA; Samhouri D
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of the Third (Booster) Dose of COVID-19 Vaccine Intention among the Healthcare Workers in Saudi Arabia: An Online Cross-Sectional Survey.
    Alobaidi S; Hashim A
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
    Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
    Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster.
    McConeghy KW; Bardenheier B; Huang AW; White EM; Feifer RA; Blackman C; Santostefano CM; Lee Y; DeVone F; Halladay CW; Rudolph JL; Zullo AR; Mor V; Gravenstein S
    JAMA Netw Open; 2022 Dec; 5(12):e2245417. PubMed ID: 36477482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
    Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
    Front Public Health; 2022; 10():914950. PubMed ID: 35903387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Theory-Based Analysis of COVID-19 Vaccine Hesitancy among African Americans in the United States: A Recent Evidence.
    Sharma M; Batra K; Batra R
    Healthcare (Basel); 2021 Sep; 9(10):. PubMed ID: 34682953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preference and Willingness to Pay for the Regular COVID-19 Booster Shot in the Vietnamese Population: Theory-Driven Discrete Choice Experiment.
    Tran BX; Do AL; Boyer L; Auquier P; Le HT; Le Vu MN; Dang THT; Cao KM; Le LDT; Cu LTN; Ly BV; Nguyen DAT; Nguyen MD; Latkin CA; Ho RCM; Ho CSH; Zhang MWB
    JMIR Public Health Surveill; 2023 Jan; 9():e43055. PubMed ID: 36599156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Wittmann I; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Polivka L; Pálosi M; Szlávik J; Rokszin G; Müller C; Szekanecz Z; Kásler M
    Front Immunol; 2022; 13():919408. PubMed ID: 35935993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study.
    Lounis M; Bencherit D; Rais MA; Riad A
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
    Steinmetz L
    BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series.
    Tan KYK; Soh ASE; Ong BWL; Chen MI; Griva K
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Vaccine Booster Hesitancy (VBH) among Healthcare Professionals of Pakistan, a Nationwide Survey.
    Arshad MS; Masood I; Imran I; Saeed H; Ahmad I; Ishaq I; Yaseen H; Akbar M; Chaudhry MO; Rasool MF
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.